ClinicalTrials.gg
CompletedNCT07889817Updated Oct 22, 2026

Telerehabilitation After Lumbar Disc Herniation Surgery

An interventional study of Home Exercise Program and Telerehabilitation-Based Exercise Program in Lumbar Disc Herniation, sponsored by Hasan Kalyoncu University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Hasan Kalyoncu University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Dec 2024, registered Oct 2026).
Updated Oct 22, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This randomized controlled trial evaluated the effectiveness of a telerehabilitation-based exercise program in individuals who had undergone surgery for lumbar disc herniation. Participants were assigned to a control group, a home exercise group, or a telerehabilitation group. The exercise programs started four weeks after surgery and continued for eight weeks, three days per week, with each session lasting 30-45 minutes. The home exercise group performed the exercise program independently at home, while the telerehabilitation group performed the same program under remote supervision of a physiotherapist using video calls. The control group continued their routine daily activities without participating in a structured exercise program during the study period. Pain, disability, physical activity, and health-related quality of life were assessed before and after the eight-week intervention period.

02

Conditions studied

  • Lumbar Disc Herniation

Keywords

  • Telerehabilitation
  • Exercise Therapy
  • Home Exercise
  • Postoperative Rehabilitation
  • Lumbar Disc Herniation
  • Pain
  • Disability
  • Physical Activity
  • Quality of Life
03

In context

Intervertebral Disc Displacement

489 studies on the registry are indexed under Intervertebral Disc Displacement; 104 are open to participants now.

This study's enrollment of 82 is above the median of 64 across 353 interventional studies indexed under Intervertebral Disc Displacement.

Browse Intervertebral Disc Displacement studies →

Lead sponsor

Hasan Kalyoncu University is the lead sponsor of 165 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants who had undergone lumbar disc herniation surgery four weeks previously
  • Age between 18 and 60 years
  • Voluntary agreement to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Presence of cognitive or physical health problems that could prevent participation in the study
  • Use of analgesic or muscle relaxant medication
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
82 participants (actual)

Study arms

  • No intervention
    Control Group

    Participants in the control group continued their routine daily activities and did not participate in a structured exercise program during the 8-week study period. After completion of the study, participants were offered an exercise program upon request.

  • Active comparator
    Home Exercise Group

    Participants in the home exercise group were taught the structured exercise program by a physiotherapist at the hospital and subsequently performed the program independently at home. The program started at the end of the fourth postoperative week and was performed three days per week for 8 weeks, with each session lasting approximately 30-45 minutes.

    Behavioral: Home Exercise Program

  • Experimental
    Telerehabilitation Group

    Participants in the telerehabilitation group received the structured exercise program under remote supervision of a physiotherapist. The program started at the end of the fourth postoperative week and continued for 8 weeks, three days per week, with each session lasting approximately 30-45 minutes. After initial instruction at the hospital, subsequent exercise sessions were supervised remotely via WhatsApp video calls.

    Behavioral: Telerehabilitation-Based Exercise Program

Interventions

  • BehavioralHome Exercise Program

    Participants received instruction on the exercise program from a physiotherapist at the hospital and subsequently performed the program independently at home. The program started at the end of the fourth postoperative week and continued for 8 weeks, three days per week, with each session lasting approximately 30-45 minutes. The program included active range-of-motion exercises, shoulder circumduction, breathing exercises, walking at a target Modified Borg Scale rating of 4-6, lower-extremity stretching, quadriceps and lumbar extensor isometric exercises, and trunk extension exercises. Exercise repetitions were progressed from 8 repetitions during the first 4 weeks to 12 repetitions during the following 4 weeks.

  • BehavioralTelerehabilitation-Based Exercise Program

    Participants performed an 8-week telerehabilitation-based exercise program under remote supervision of a physiotherapist via video calls. The program was performed three days per week, with each session lasting approximately 30-45 minutes.

06

What researchers measure

Primary outcomes

  1. Change in Functional Disability Assessed by the Oswestry Disability Index (ODI)

    The Oswestry Disability Index (ODI) assesses functional disability associated with low back pain. Scores range from 0% to 100%, with higher scores indicating greater functional disability and a worse outcome. Changes in ODI scores were assessed from baseline to the end of the eight-week intervention period.

    Time frame: Baseline and 8 weeks

  2. Pain Intensity Assessed by the Visual Analog Scale (VAS)

    The Visual Analogue Scale (VAS) assesses pain intensity on a scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity and a worse outcome. Changes in VAS scores were assessed from baseline to the end of the eight-week intervention period.

    Time frame: Baseline and 8 weeks

  3. Physical Activity Assessed by the International Physical Activity Questionnaire-Short Form (IPAQ)

    The International Physical Activity Questionnaire-Short Form (IPAQ-SF) assesses physical activity performed during the preceding seven days. Total physical activity is calculated using walking, moderate-intensity, and vigorous-intensity activities and expressed as metabolic equivalent task minutes per week (MET-min/week). Scores range from a minimum of 0 MET-min/week to no fixed maximum. Higher scores indicate greater levels of physical activity. Changes in total physical activity scores were assessed from baseline to the end of the eight-week intervention period.

    Time frame: Baseline and 8 weeks

  4. Health-Related Quality of Life Assessed by the 36-Item Short Form Health Survey (SF-36)

    The Short Form-36 (SF-36) Health Survey assesses health-related quality of life across eight domains: physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health. Each domain is scored from 0 to 100, with higher scores indicating better health-related quality of life. Changes in SF-36 scores were assessed from baseline to the end of the eight-week intervention period.

    Time frame: Baseline and 8 weeks

07

Study locations

1 site
  • Inonu University Turgut Ozal Medical Center
    Malatya, 44280, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2024 to primary completion in Oct 2026, 22 months.

Of 180 non-industry interventional studies with no phase under Intervertebral Disc Displacement, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's 22 months is above that.

Counting every sponsor, half of 196 studies reached it within 12 months; a quarter within 6 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 14, 2026
First posted
Oct 22, 2026
StartActual
Dec 1, 2024
Primary completionActual
Oct 1, 2026
CompletionActual
Oct 1, 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07889817
Responsible party
İlker DEMİR (Physiotherapist, PhD, Inonu University) — Principal investigator
First posted
Oct 22, 2026
Start date
Dec 1, 2024
Primary completion
Oct 1, 2026
Completion
Oct 1, 2026
Last update
Oct 22, 2026

Study contacts

İlker Demir
principal investigator · Inonu University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion